VITALITY BIOPHARMA INC (OTCMKTS:VBIO) Short Interest Decreased By 20.55%

June 13, 2018 - By Dolores Ford

The stock of VITALITY BIOPHARMA INC (OTCMKTS:VBIO) registered a decrease of 20.55% in short interest. VBIO’s total short interest was 183,600 shares in June as published by FINRA. Its down 20.55% from 231,100 shares, reported previously. With 106,500 shares average volume, it will take short sellers 2 days to cover their VBIO’s short positions. The short interest to VITALITY BIOPHARMA INC’s float is 0.99%.

The stock decreased 1.82% or $0.02 during the last trading session, reaching $1.35. About 55,636 shares traded. Vitality Biopharma, Inc. (OTCMKTS:VBIO) has 0.00% since June 13, 2017 and is . It has underperformed by 12.57% the S&P500.

Vitality Biopharma, Inc. focuses on the development of cannabinoid pharmaceuticals for the treatment of neurological and inflammatory disorders in the United States. The company has market cap of $30.37 million. The Company’s products in pipeline include VITA-100, an oral cannabinoid formulation that is used for the acute treatment of inflammatory bowel disease and narcotic bowel syndrome; and VITA-210, a cannabinoid formulation, which is in preclinical studies for use in the chronic treatment of neuropathic pain, irritable bowel syndrome, muscle spasticity in multiple sclerosis, and opioid-induced bowel dysfunction. It currently has negative earnings. The firm was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: